SCHEMBL10141553

SCHEMBL10141553

Cc1ccccc1Cn1cc(C(C)C)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
MAPT P10636 2/20 0.46
PKM P14618 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
HPGD P15428 3/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
CHRNE Q04844 1/20 0.42
RAB9A P51151 3/20 0.41
KDM4E B2RXH2 2/20 0.41
NPC1 O15118 2/20 0.41
ADORA2A P29274 1/20 0.41
ADORA2B P29275 1/20 0.41
ADORA1 P30542 1/20 0.41
CYP11B1 P15538 2/20 0.41
CYP11B2 P19099 2/20 0.41
POLB P06746 1/20 0.40
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
GAA P10253 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19077851 0.83 LMNA (0.44) ALDH1A1MAPTPKML3MBTL1HPGD
SCHEMBL19158354 0.81 ALDH1A1 (0.49) ALDH1A1MAPTPKML3MBTL1HPGD
SCHEMBL19343281 0.80 GABRA5 (0.41) ALDH1A1MAPTPKML3MBTL1HPGD
SCHEMBL3611045 0.80 ALDH1A1 (0.69) ALDH1A1MAPTPKML3MBTL1HPGD
SCHEMBL19077850 0.79 CREBBP (0.56) ALDH1A1MAPTPKML3MBTL1SMN1; SMN2
SCHEMBL29050052 0.79 ALDH1A1 (0.51) ALDH1A1MAPTPKML3MBTL1HPGD
SCHEMBL10141551 0.78 L3MBTL1 (0.59) ALDH1A1L3MBTL1KDM4EADORA2AADORA2B
SCHEMBL19077853 0.78 ALDH1A1 (0.41) ALDH1A1MAPTPKML3MBTL1KDM4E
SCHEMBL18586320 0.75 ALDH1A1 (0.47) ALDH1A1MAPTPKML3MBTL1HPGD
SCHEMBL19077852 0.75 NPBWR1 (0.46) ALDH1A1MAPTRAB9AKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9676759-B2 Isoindolinone inhibitors of phosphatidylinositol 3-kinase VERTEX PHARMACEUTICALS INCORPORATED (US) 2017-06-13 US disclosed
US-20140038936-A1 ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE VERTEX PHARMACEUTICALS INCORPORATED 2014-02-06 US disclosed
US-8466288-B2 Isoindolinone inhibitors of phosphatidylinositol 3-kinase VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-06-18 US disclosed
US-20120202784-A1 ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-08-09 US disclosed
US-20120040950-A1 ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140038936-A1 ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE PIK3CD, PIK3CA, PIK3R5 ALDH1A1 3381/4885MAPT 2239/4885PKM 1364/4885
US-20120040950-A1 ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE PIK3CD, PIK3CA, PIK3R5 ALDH1A1 3381/4885MAPT 2239/4885PKM 1364/4885
US-20120202784-A1 ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE PIK3CD, PIK3CA, PIK3R5 ALDH1A1 3381/4885MAPT 2239/4885PKM 1364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.